Endocrine Abstracts

Introduction: The COVID-19 pandemic has affected the delivery of NET services and patient care. We retrospectively analysed the recovery of NET service provision over the COVID-19 recovery period 2020-2021.Method: The NET database was searched using 3 NET physician codes. Anonymised data was analysed, including PRRT, MIBG, endoscopy and bronchoscopy rates. In February 2022, patient satisfaction questionnaires were posted out to 87 randomly selected NET p...

Introduction: The response to SARS-CoV-2 lead to interventions to mitigate the pandemic. We retrospectively analysed the effect of changes on key NET services. These included: change in clinic media, absolute change in numbers for endoscopy and bronchoscopy, nuclear imaging, SSA administration and PRRT numbers compared with 2019.Method: The NET database was analysed. Endoscopy rates on a monthly basis were reviewed. Two bespoke postal patient surveys wer...

Introduction: Pulmonary neuroendocrine tumours (pulNETs) histologically encompass: small cell, large cell, typical (TC) and atypical carcinoid (AC). Diffuse idiopathic pulmonary neuroendocrine hyperplasia (DIPNECH) is a very rare condition but potentially progress to pulNET and is associated with MEN. Advances in treatment have modified management, and there have been recommendations to use Ki67 for grading. However there is a paucity of randomized studies.<p class="abstex...

Introduction: The COVID-19 pandemic has affected patient care and experience. We assessed the evolution of NET patient perceptions during and peri-pandemic via a bespoke patient satisfaction survey.Methods: In February 2022, questionnaires with a pre-paid return envelope were posted out to 87 randomly selected NET patients, treated between January and December 2021. This consisted of 29 questions covering: initial contact, physician care and support, ill...